Literature DB >> 26141580

Urticaria Guidelines: Consensus and Controversies in the European and American Guidelines.

Lauren M Fine1, Jonathan A Bernstein.   

Abstract

Urticaria can present acutely and be self-limiting or become chronic and persist for weeks, months, or years. In either case, the condition may have a significant impact on the patient's quality of life. Two major consensus groups, the EAACI/WAO and the AAAAI/ACAAI Joint Task Force, have written guidelines on the diagnosis and management of urticaria. While both agree on most points regarding the definition, general evaluation, and treatment, there are some differences which exist. The guidelines, which are written to assist both primary practitioners and specialists in managing their patients with urticaria, have been developed based on scientific evidence, and when insufficient evidence is available, then recommendations are based on expert consensus opinion. The majority of the differences between the two guidelines pertain to recommendations based on expert opinion because of weak scientific evidence. Within this document, we compare the recommendations of these two groups, highlighting the key similarities and differences.

Entities:  

Mesh:

Year:  2015        PMID: 26141580     DOI: 10.1007/s11882-015-0535-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  37 in total

Review 1.  Chronic urticaria: pathophysiology and etiology, or the what and why.

Authors:  Alan L Schocket
Journal:  Allergy Asthma Proc       Date:  2006 Mar-Apr       Impact factor: 2.587

2.  The natural history of chronic urticaria in childhood: a prospective study.

Authors:  Somboon Chansakulporn; Sureerat Pongpreuksa; Preeda Sangacharoenkit; Punchama Pacharn; Nualanong Visitsunthorn; Pakit Vichyanond; Orathai Jirapongsananuruk
Journal:  J Am Acad Dermatol       Date:  2014-07-11       Impact factor: 11.527

3.  A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.

Authors:  Sarbjit Saini; Karin E Rosen; Hsin-Ju Hsieh; Dennis A Wong; Edward Conner; Allen Kaplan; Sheldon Spector; Marcus Maurer
Journal:  J Allergy Clin Immunol       Date:  2011-07-18       Impact factor: 10.793

4.  Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria.

Authors:  Susan D Mathias; Ross D Crosby; James L Zazzali; Marcus Maurer; Sarbjit S Saini
Journal:  Ann Allergy Asthma Immunol       Date:  2011-11-02       Impact factor: 6.347

5.  Etiologic factors in childhood chronic urticaria.

Authors:  M Volonakis; A Katsarou-Katsari; J Stratigos
Journal:  Ann Allergy       Date:  1992-07

6.  The natural history and response to therapy of chronic urticaria and angioedema.

Authors:  J H Quaranta; A S Rohr; G S Rachelefsky; S C Siegel; R M Katz; S L Spector; M R Mickey
Journal:  Ann Allergy       Date:  1989-05

Review 7.  Omalizumab in asthma: approval and postapproval experience.

Authors:  Dean T Chiang; Justin Clark; Thomas B Casale
Journal:  Clin Rev Allergy Immunol       Date:  2005-08       Impact factor: 8.667

8.  Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients.

Authors:  M H Platzer; C E H Grattan; L K Poulsen; P S Skov
Journal:  Allergy       Date:  2005-09       Impact factor: 13.146

Review 9.  Chronic urticaria: pathogenesis and treatment.

Authors:  Allen P Kaplan
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

10.  Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.

Authors:  E Nettis; M C Colanardi; M T Paradiso; A Ferrannini
Journal:  Clin Exp Allergy       Date:  2004-09       Impact factor: 5.018

View more
  10 in total

Review 1.  Current and future therapies for the treatment of histamine-induced angioedema.

Authors:  Christine James; Jonathan A Bernstein
Journal:  Expert Opin Pharmacother       Date:  2017-01-25       Impact factor: 3.889

2.  TOXICAN: a guide for grading dermatological adverse events of cancer treatments.

Authors:  L Peuvrel; J Cassecuel; C Bernier; G Quéreux; M Saint-Jean; M Le Moigne; C Frénard; A Khammari; B Dréno
Journal:  Support Care Cancer       Date:  2018-03-12       Impact factor: 3.603

3.  Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results.

Authors:  Marcus Maurer; Ana Giménez-Arnau; Luis Felipe Ensina; Chia-Yu Chu; Xavier Jaumont; Paolo Tassinari
Journal:  World Allergy Organ J       Date:  2020-09-12       Impact factor: 4.084

4.  Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador.

Authors:  A Cherrez; M Maurer; K Weller; J C Calderon; D Simancas-Racines; I Cherrez Ojeda
Journal:  World Allergy Organ J       Date:  2017-05-23       Impact factor: 4.084

5.  Analysis of the changes in Th9 cells and related cytokines in the peripheral blood of spontaneous urticaria patients.

Authors:  Renshan Zheng; Lei Qian; Jianxiu Yu; Ming Li; Qing Qian
Journal:  Biomed Rep       Date:  2017-05-03

6.  Anaphylaxis in a 4-year-old male caused by contact with grasses: a case report.

Authors:  Germán Darío Ramón; Victor H Croce; Iván Chérrez Ojeda
Journal:  World Allergy Organ J       Date:  2017-01-19       Impact factor: 4.084

7.  Management of chronic spontaneous urticaria: a worldwide perspective.

Authors:  Pavel Kolkhir; Dmitry Pogorelov; Razvigor Darlenski; Marco Caminati; Luciana Kase Tanno; Duy Le Pham; Alexei Gonzalez-Estrada; Darío Antolín-Amérigo; Ves Dimov; Karsten Weller; Mario Sánchez-Borges; Ignacio Ansotegui; Marcus Maurer
Journal:  World Allergy Organ J       Date:  2018-07-04       Impact factor: 4.084

Review 8.  Chronic Urticaria: An Overview of Treatment and Recent Patents.

Authors:  Kam L Hon; Alexander K C Leung; Wing G G Ng; Steven K Loo
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2019

9.  Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.

Authors:  Oliviero Rossi; Angelo Piccirillo; Enrico Iemoli; Annalisa Patrizi; Luca Stingeni; Stefano Calvieri; Massimo Gola; Paolo Dapavo; Antonio Cristaudo; Leonardo Zichichi; Laura Losappio; Fabiana Saccheri; Elide Anna Pastorello
Journal:  World Allergy Organ J       Date:  2020-12-08       Impact factor: 4.084

10.  Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria.

Authors:  Mignon T van den Elzen; Harmieke van Os-Medendorp; Imke van den Brink; Karin van den Hurk; Ouliana I Kouznetsova; Alexander S H J Lokin; Anna-Marijke Laheij-de Boer; Heike Röckmann; Carla A F M Bruijnzeel-Koomen; André C Knulst
Journal:  Clin Transl Allergy       Date:  2017-02-14       Impact factor: 5.871

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.